Cargando…
Analogs of FTY720 inhibit TRPM7 but not S1PRs and exert multimodal anti-inflammatory effects
TRPM7, a TRP channel with ion conductance and kinase activities, has emerged as an attractive drug target for immunomodulation. Reverse genetics and cell biological studies have already established a key role for TRPM7 in the inflammatory activation of macrophages. Advancing TRPM7 as a viable molecu...
Autores principales: | Busey, Gregory W., Manjegowda, Mohan C., Huang, Tao, Iobst, Wesley H., Naphade, Shardul S., Kennedy, Joel A., Doyle, Catherine A., Seegren, Philip V., Lynch, Kevin R., Desai, Bimal N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Rockefeller University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10635799/ https://www.ncbi.nlm.nih.gov/pubmed/37943249 http://dx.doi.org/10.1085/jgp.202313419 |
Ejemplares similares
-
FTY720-derivatives do not induce FTY720-like lymphopenia
por: Segura-Ulate, Ismael, et al.
Publicado: (2017) -
FTY720, a sphingosine analog, altered placentome histoarchitecture in ewes
por: Dunlap, Kathrin A., et al.
Publicado: (2020) -
FTY720 attenuates excitotoxicity and neuroinflammation
por: Cipriani, Raffaela, et al.
Publicado: (2015) -
New FTY720-docetaxel nanoparticle therapy overcomes FTY720-induced lymphopenia and inhibits metastatic breast tumour growth
por: Alshaker, Heba, et al.
Publicado: (2017) -
Synthesis of Novel FTY720 Analogs with Anticancer Activity through PP2A Activation
por: Shrestha, Jitendra, et al.
Publicado: (2018)